Eli Lilly Buys Rights to Merck Drug
523577
Drug maker Eli Lilly and Co. said Wednesday that it acquired the rights to an insomnia treatment developed by Germany pharmaceutical company Merck KGaA.
269527
Teva Pharmaceuticals of Israel, the largest generic-drug maker in the world, announced yesterday that it was acquiring the Rockville biotechnology company CoGenesys for $400 million.
665690
The developing biopharmaceutical company announces a share offering.
541099
German pharmaceuticals company Merck KGaA has taken a majority stake in Switzerland's Serono SA and was aiming at a full takeover worth 16.6 billion Swiss francs (10.46 billion euros).
768370
Billionaire investor Carl Icahn yesterday offered to purchase Mylan Laboratories for $20 per share, part of his plan to derail the Canonsburg generic drug maker&#39;s proposed acquisition of King Pharmaceuticals.
700315
German drugmaker Merck KGaA   unveiled a surprise 16.6-billion-Swiss franc ($13.3  billion) deal to buy Swiss biotech firm Serono on Thursday,  creating a new force in European pharmaceuticals.
287707
Serono SA , one of the world's largest biotechnology companies, was bought yesterday by German chemical giant Merck KGaA in a deal worth more than $13 billion.
79075
Eli Lilly pushed Zyprexa, a drug for schizophrenia and bipolar disorder, as a treatment for older patients with dementia, according to marketing materials.
296490
The small pharmaceutical firm signs another big deal.
660344
Israel's Teva Pharmaceutical  Industries Ltd. has agreed to buy Pfizer Inc.'s Italian generic  drug marketing company and is hungry for more acquisitions, the  drugmaker said on Tuesday.
191590
Icos Corp.'s  board said on Monday it had agreed to a sweetened takeover offer from Eli Lilly and Co.  of $34 per share in cash, up from a previous offer of $32 per share.
515541
INDIANAPOLIS, July 24  â Eli Lilly, with help from its core medicines Zyprexa and Cymbalta, beat Wall Streetâs second-quarter expectations Tuesday, although profits fell 19 percent at the pharmaceutical company because of acquisition costs.
142333
German chemicals and pharmaceuticals giant Bayer said it had acquired the marketing rights for GlaxoSmithKline's erectile dysfunction treatment Levitra in a number of countries outside the US for 208 million euros (272 million dollars).
514951
Eli Lilly & Co  and Japan's Daiichi Sankyo Co Ltd  said on Friday they had asked U.S. regulators to approve prasugrel, a blood clot preventer that is the U.S. drug maker's most important experimental product.
741854
The generic drugmaker buys an Indian firm to strengthen its long-term prospects.
17811
Nastech shares jump before the bell after companies say they will jointly create the new treatment. NEW YORK  - Merck &amp; Co.
526091
Drugmaker Eli Lilly and Co. LLY.N on  Wednesday said its restructuring will result in a  fourth-quarter charge of 24 cents to 27 cents per share, above  its previous estimate of 19 to 24 cents per share.